Robotic Versus Laparoscopy NOSE for Stage I-III Left-sided Colon Cancer
Recruiting · NCT05970133 · Interventional (participants receive a specific treatment) · Lead sponsor: National Taiwan University Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Colectomy with NOSE procedure
What this trial is about
In this project, the investigator aims to provide the level 1 evidence for the comparison of robotic versus laparoscopic NOSE for the surgery of stage I-III colorectal cancer. the investigator hypothesize that, with the increased maneuverability of the current robotic system, robotic surgery will be a good option for patients with stage I-III colorectal cancer requiring a NOSE procedure.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Primary colon cancers located at the left sided colonic anatomic location, including distal transverse colon, colonic splenic flexure, descending colon, sigm oid descending colonic junction, sigmoid colon and upper rectum that required the mobilization of colonic splenic flexure to facilitate a curative resection and trans anal specimen extraction ;
- TNM Stage I III adenocarcinomas;
- Curative and elective surgery;
- American Society of Anesthesiology (ASA) class I to III patients;
- Age \>18 years.
Exclusion criteria
- Cecal, ascending, the proximal and middle transverse colon cancers; and the middle or lower rectal cancers;
- Emergency or palliative surgery;
- Evidence of disseminated disease or adjacent organ invasion;
- Primary tumor mass \>8 cm in diameter;
- Morbidly obese patients, that is, body mass index (BMI) ≥40 kg/m 2 ;
- Previous major surgery of upper abdomen or pelvis
Where it is running
1 location listed.
- National Taiwan University Hospital - Taipei, Taiwan